{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-169651","form_type":"8-K","ticker":null,"cik":"0001800682","company_name":"Cano Health, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.652751+00:00","generated_at":"2026-06-13T21:35:24.069446+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cano Health CEO Marlow Hernandez resigns; Mark Kent appointed Interim CEO","bullets":["CEO Marlow Hernandez resigned effective June 16, 2023; remains on Board.","Mark Kent, current Chief Strategy Officer, appointed Interim CEO effective immediately.","Kent receives $475k base salary, $325k target cash incentive, $1.5M annual equity, $1.5M RSUs vesting June 2024.","Board will conduct external search for permanent CEO and refresh Board with new independent directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-169651","json":"https://secwatch.observer/filing/0001193125-23-169651.json","markdown":"https://secwatch.observer/filing/0001193125-23-169651.md","text":"https://secwatch.observer/filing/0001193125-23-169651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/d512837d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:35:24.069446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a0c0eeeaf","claim":"Mark Kent was appointed as Interim Chief Executive Officer at Cano Health, Inc..","evidence_excerpt":"Effective immediately, on June 16, 2023, the Board of Directors (the “ Board ”) of Cano Health, Inc. (the “ Company ”) elected the Company’s current Chief Strategy Officer, Mr. deMarquette (“ Mark ”) Kent, as the Company’s Interim Chief Executive Officer (the “ Interim CEO ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"88e5c4bf70","claim":"Marlow Hernandez resigned as Chief Executive Officer at Cano Health, Inc..","evidence_excerpt":"Mr. Kent will replace Dr. Marlow Hernandez, who tendered his resignation as the Company’s Chief Executive Officer, as well as all positions he holds at the Company’s subsidiaries, effective immediately on June 16, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800682/000119312523169651/0001193125-23-169651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}